Gilberto Fronza

8PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersMolecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 22, 2023
Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study.

Riccardo Bomben, Francesca Maria Rossi, Filippo Vit

|Jul 12, 2022
MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells.

Serena Matis, Anna Grazia Recchia, Monica Colombo

|Jul 21, 2021
<i>TP53</i> Mutations with Low Variant Allele Frequency Predict Short Survival in Chronic Lymphocytic Leukemia.

Riccardo Bomben, Francesca Maria Rossi, Filippo Vit

|Mar 06, 2021
Evaluating the Influence of a G-Quadruplex Prone Sequence on the Transactivation Potential by Wild-Type and/or Mutant P53 Family Proteins through a Yeast-Based Functional Assay.

Paola Monti, Vaclav Brazda, Natália Bohálová

|Feb 10, 2021
Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma.

Barbara Marengo, Alessandra Pulliero, Maria Valeria Corrias

|Jan 12, 2021
Antitumor Effects of PRIMA-1 and PRIMA-1<sup>Met</sup> (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?

Paola Menichini, Paola Monti, Andrea Speciale

Pageof 2

Frequent Collaborators

5 joint publications

Paola Monti

4 joint publications

Giovanna Cutrona

4 joint publications

Fortunato Morabito

2 joint publications

Jerry Polesel